The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma.
about
Melatonin and stable circadian rhythms optimize maternal, placental and fetal physiologySequencing ASMT identifies rare mutations in Chinese Han patients with autismMelatonin attenuates the focal cerebral ischemic injury by inhibiting the dissociation of pBad from 14-3-3Cellular and biochemical actions of melatonin which protect against free radicals: role in neurodegenerative disordersScientific basis for the potential use of melatonin in bone diseases: osteoporosis and adolescent idiopathic scoliosis.Melatonin combats molecular terrorism at the mitochondrial level.Antiinflammatory activity of melatonin in central nervous systemA double-blind, placebo-controlled intervention trial of 3 and 10 mg sublingual melatonin for post-concussion syndrome in youths (PLAYGAME): study protocol for a randomized controlled trialMelatonin alleviates myosin light chain kinase expression and activity via the mitogen-activated protein kinase pathway during atherosclerosis in rabbits.Association between serum malondialdehyde levels and mortality in patients with severe brain trauma injury.Total antioxidant capacity is associated with mortality of patients with severe traumatic brain injuryNeuroimmune endocrine effects of antidepressantsMedical therapies for concussion.Melatonin and oral cavityMelatonin: bone metabolism in oral cavity.Melatonin Counteracts at a Transcriptional Level the Inflammatory and Apoptotic Response Secondary to Ischemic Brain Injury Induced by Middle Cerebral Artery Blockade in Aging RatsExacerbated mechanical hyperalgesia in rats with genetically predisposed depressive behavior: role of melatonin and NMDA receptors.Peripheral reproductive organ health and melatonin: ready for prime time.Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases.Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats.Melatonin ameliorates injury and specific responses of ischemic striatal neurons in ratsMelatonin, consciousness, and traumatic stress.Melatonin and reproduction revisited.Application of LC and LC-MS to the analysis of melatonin and serotonin in edible plants.Potential utility of melatonin as an antioxidant during pregnancy and in the perinatal period.From the field of play to the field of combat: a review of the pharmacological management of concussion.A review of the use of melatonin in ulcerative colitis: experimental evidence and new approaches.Delivery of pineal melatonin to the brain and SCN: role of canaliculi, cerebrospinal fluid, tanycytes and Virchow-Robin perivascular spaces.Postconcussion Syndrome: A Review.Melatonin as a pro-osteogenic agent in oral implantology: a systematic review of histomorphometric outcomes in animals and quality evaluation using ARRIVE guidelines.Changes in melatonin levels in transgenic 'Micro-Tom' tomato overexpressing ovine AANAT and ovine HIOMT genes.Posttranscriptional regulation of pineal melatonin synthesis in Octodon degus.Melatonin modulates the expression of VEGF and HIF-1 alpha induced by CoCl2 in cultured cancer cells.Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells.Cultured rat cortical astrocytes synthesize melatonin: absence of a diurnal rhythm.Serum melatonin levels in survivor and non-survivor patients with traumatic brain injury.Dual effects of melatonin on oxidative stress after surgical brain injury in rats.Combination antioxidant effect of erythropoietin and melatonin on renal ischemia-reperfusion injury in rats.The role of melatonin in the pathogenesis of multiple sclerosis: a case-control study.Melatonin restricts Pb-induced PCD by enhancing BI-1 expression in tobacco suspension cells.
P2860
Q26825609-85C843C4-5965-4E37-9005-BBEB5C462107Q28485180-2AC1D631-A741-4B1A-A1A6-352D27C22DFCQ28576697-834866E1-EC7D-43BC-9E40-CC06551D3239Q28754228-2201753D-DA6A-4FDE-910F-5FD90C289046Q34211436-62D6064A-0473-4743-B413-E69A65B1FDE7Q34359618-C9857A00-6C0F-4C13-903F-26A5D2DB7D1BQ34402174-68103E56-0008-44E9-9025-F9051B64A64DQ34486287-94AF5E6E-7CB0-478A-AC91-9F2BBFB12A2CQ34540863-478FEE76-5A3F-4293-9200-D906863F9923Q34751405-5AA3A5DC-40ED-4348-A1B9-5163192D5922Q35708922-C3F635F3-5AAC-40A2-A6A1-9BB37682BAC4Q35758842-ABA1A867-EC85-4728-BB9D-8FDEF9F1F38AQ35986783-2CB5EBB9-571C-4585-B1F8-17FFAE2F9AD4Q36076041-B0F52385-084C-4C14-8CB0-615F40FBFE4DQ36178389-22F545DE-C9D3-4F56-BB2D-E1F212B6E293Q36274443-DD1A6402-EE31-49B0-9D09-65300247E48CQ36389131-6571DF53-51B2-4D00-9041-967869E85925Q36820433-C9428EB3-A87B-40C8-A0ED-3E911B3204F8Q37007219-4742D10A-D2F2-49CC-98E8-8CDDA05D3D84Q37036314-E9CAEDC0-3AFA-46CA-BD4A-956BF65275C6Q37047638-26BE9C8D-D80A-4E11-BD4B-28A995A41011Q37138014-2195B0A0-55AE-4277-8937-5FF929257D25Q37480368-442FDEB0-8108-4D9B-8611-AED9894D6B9DQ37856990-F8BF9986-AE03-4AA1-8E40-DEA3B0EE708EQ37873941-7B610942-5287-41CF-97EE-C40DA6842A0DQ37979980-870835A8-D0BD-484F-BD3D-650B5C73D3C6Q38163844-A70A7EA6-2CFC-4949-BC84-AD41D013442FQ38189661-A03C3B1E-2103-46FE-89E5-95FC56051ECCQ38261461-4EC43A63-EB90-42BB-AF1E-CDA1039085DDQ38813126-9FDA2FEB-194A-490D-B16C-17B10A94E33EQ39574662-BFD3EC64-C5B0-49A5-842B-D907AA335AAEQ39604520-638A4A92-7132-43C7-89AB-71EE84703410Q40010652-D994A940-064A-4E3D-8D09-4D9AD3BC8649Q40035889-A9850869-92E4-479D-BC19-473BE273EFC0Q40084744-0DC03DAB-91DD-41C5-8E9F-E9BB5974C794Q41065798-BB3E2E30-4CE8-492A-892B-D5A2342378C6Q41854597-D05CF1A1-0832-4B6D-A455-A03251E5642CQ41975960-C7505D78-B933-43D3-A292-77AAFC262D33Q42148297-BF493C6D-0AA1-404E-AD03-F43A11F9DBFFQ42182220-F3FA125A-F76E-47A1-997D-B75D294A6F48
P2860
The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma.
@ast
The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma.
@en
type
label
The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma.
@ast
The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma.
@en
prefLabel
The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma.
@ast
The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma.
@en
P2093
P2860
P1476
The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma
@en
P2093
Manchester LC
Murillo-Cabezas F
P2860
P356
10.1111/J.1600-079X.2006.00376.X
P577
2007-01-01T00:00:00Z